NCT05392530View on ClinicalTrials.gov

A Study of Two Different Test Formulations Compared to the Reference Formulation of Macitentan in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

August 30, 2022

Study Completion Date

September 14, 2022

Conditions

Healthy

Interventions

DRUG

Macitentan

Macitentan film coated tablets will be administered orally as per assigned treatment sequence.

Trial Locations (1)

2650

SGS Belgium NV, Edegem

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Actelion

INDUSTRY